What is physIQ?
PhysIQ operates at the forefront of digital medicine, leveraging continuous wearable biosensor data and sophisticated analytics to generate unprecedented health insights. Its enterprise-ready cloud platform is designed to collect and process data from any wearable biosensor, supported by a comprehensive portfolio of FDA-cleared analytics. The company has distinguished itself through rigorous clinical studies in digital medicine, pioneering the development, validation, and regulatory approval of artificial intelligence-based analytics. PhysIQ's solutions are applied across clinical trial support and broader healthcare sectors, converting continuous physiological data into actionable intelligence for health systems, payers, and pharmaceutical companies.
How much funding has physIQ raised?
physIQ has raised a total of $19.9M across 5 funding rounds:
Series A
$4.6M
Private Equity
$3.6M
Series B
$8M
Unspecified
$3.3M
Debt
$350K
Series A (2014): $4.6M with participation from LionBird Ltd.
Private Equity (2016): $3.6M, investors not publicly disclosed
Series B (2017): $8M supported by GF Securities, Quark Venture Inc., LionBird, and 4490 Ventures
Unspecified (2019): $3.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in physIQ
Quark Venture Inc.
Quark Venture LP is a venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms. The company's strategic goal is to continually support such entrepreneurial biotechnology companies to efficiently improve the technology platform and obtain high-growth value by providing diversified healthcare products or services. Quark's proven success is achieved through long-term relationships with target companies that share similar technology innovation visions.
LionBird
LionBird (Ventures) Ltd. invests in innovative health-tech startups that aim to transform the healthcare landscape through technology. They provide pre-scale capital and support to teams dedicated to improving healthcare solutions. The company seeks to establish long-term relationships with its portfolio companies, focusing on those that demonstrate unique insights and competitive advantages. LionBird is particularly interested in startups that are designed to become leaders in their respective fields.
4490 Ventures
After a decade of agency and in-house marketing experience, Katie Lord founded her company to close the ever-present gap between business ideas and creative execution. With a passion for design and a knack for strategy, Katie was able to meld her marketing success into a transparent business model to help people bring their ideas to life. Focusing on branding, impactful marketing and website creation, Katie Lord Inc produces agency quality work, without the cost. Throughout her career, Katie Lord has helped companies achieve over $50,000,000 in venture capital funding through marketing and design. Having held high level positions such as a Marketing Manager at SMS Assist (now a $1B+ company) and most recently Art Director at the Tribune (Motiv8 Agency), she has valuable experience working with and at the C-level of companies to guide their marketing strategies and execute creative design. Based in Chicago, with national reach, Katie Lord Inc is poised to position your business to get the attention it deserves. Katie grew up in the Upper Peninsula of Michigan with her mom and identical twin. For the first seven years of her life, Katie's mother drove two hours each direction to earn a degree in education. That dedication, determination and overall work ethic inspired Katie to start her own company, ingraining in her the understanding of what it means to be a woman founder. She carries that knowledge with her to every meeting. Katie currently lives in Chicago and enjoys spending time traveling and hanging out with her samoyed named Ymka.
What's next for physIQ?
The substantial enterprise-level funding and recent strategic investment position physIQ for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its AI-driven analytics and broaden the reach of its digital medicine platform. With a focus on enhancing healthcare delivery and clinical trial efficiency, physIQ is poised to solidify its leadership in translating complex physiological data into critical health insights, driving innovation across the healthcare ecosystem.
See full physIQ company page